These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 30269480

  • 1. Label-Free and Real-Time Detection of Tuberculosis in Human Urine Samples Using a Nanophotonic Point-of-Care Platform.
    Ramirez-Priego P, Martens D, Elamin AA, Soetaert P, Van Roy W, Vos R, Anton B, Bockstaele R, Becker H, Singh M, Bienstman P, Lechuga LM.
    ACS Sens; 2018 Oct 26; 3(10):2079-2086. PubMed ID: 30269480
    [Abstract] [Full Text] [Related]

  • 2. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
    Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T.
    J Clin Microbiol; 2018 Dec 26; 56(12):. PubMed ID: 30257899
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sensitive Urine Immunoassay for Visualization of Lipoarabinomannan for Noninvasive Tuberculosis Diagnosis.
    Chen P, Meng Y, Liu T, Peng W, Gao Y, He Y, Qu R, Zhang C, Hu W, Ying B.
    ACS Nano; 2023 Apr 11; 17(7):6998-7006. PubMed ID: 37010068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence.
    Sarkar P, Biswas D, Sindhwani G, Rawat J, Kotwal A, Kakati B.
    Postgrad Med J; 2014 Mar 11; 90(1061):155-63. PubMed ID: 24429376
    [Abstract] [Full Text] [Related]

  • 8. A sensitive urinary lipoarabinomannan test for tuberculosis.
    Hamasur B, Bruchfeld J, van Helden P, Källenius G, Svenson S.
    PLoS One; 2015 Mar 11; 10(4):e0123457. PubMed ID: 25905641
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study.
    de Vasconcellos K, Ramjathan P, Singh D.
    BMC Infect Dis; 2021 Mar 19; 21(1):281. PubMed ID: 33740905
    [Abstract] [Full Text] [Related]

  • 11. Plastic-Chip-Based Magnetophoretic Immunoassay for Point-of-Care Diagnosis of Tuberculosis.
    Kim J, Jang M, Lee KG, Lee KS, Lee SJ, Ro KW, Kang IS, Jeong BD, Park TJ, Kim HJ, Lee J.
    ACS Appl Mater Interfaces; 2016 Sep 14; 8(36):23489-97. PubMed ID: 27548010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS, Aung NM, Htet ZW, Boyd MA, Saw HA, Anstey NM, Kyi TT, Cooper DA, Kyi MM, Hanson J.
    BMC Med; 2017 Aug 04; 15(1):145. PubMed ID: 28774293
    [Abstract] [Full Text] [Related]

  • 14. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J, Theron G, Chanda D, Clowes P, Rachow A, Lesosky M, Hoelscher M, Mwaba P, Pym A, Dheda K, TB-NEAT team.
    BMC Infect Dis; 2015 Jul 09; 15():262. PubMed ID: 26156025
    [Abstract] [Full Text] [Related]

  • 15. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS, Kadzirange G, Bandason T, Chipiti MM, Gwambiwa B, Makoga F, Chungu P, Kaguru P, Dheda K.
    BMC Infect Dis; 2016 Jan 22; 16():20. PubMed ID: 26797499
    [Abstract] [Full Text] [Related]

  • 16. The cyanobacterial lectin, microvirin-N, enhances the specificity and sensitivity of lipoarabinomannan-based TB diagnostic tests.
    van der Horst M, Karamchand L, Bauer WS, Nel AJM, Blackburn JM, Wright DW.
    Analyst; 2021 Feb 21; 146(4):1207-1215. PubMed ID: 33367346
    [Abstract] [Full Text] [Related]

  • 17. Detection and Quantification of HspX Antigen in Sputum Samples Using Plasmonic Biosensing: Toward a Real Point-of-Care (POC) for Tuberculosis Diagnosis.
    Peláez EC, Estevez MC, Mongui A, Menéndez MC, Toro C, Herrera-Sandoval OL, Robledo J, García MJ, Portillo PD, Lechuga LM.
    ACS Infect Dis; 2020 May 08; 6(5):1110-1120. PubMed ID: 32233503
    [Abstract] [Full Text] [Related]

  • 18. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S, Triulzi I, Ciccacci F, Palla I, Palombi L, Marazzi MC, Giuliano M, Floridia M, Mancinelli S, Mutemba E, Turchetti G.
    PLoS One; 2018 May 08; 13(7):e0200523. PubMed ID: 30024890
    [Abstract] [Full Text] [Related]

  • 19. Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial.
    Naidoo P, Esmail A, Peter JG, Davids M, Fadul M, Dheda K.
    Int J Infect Dis; 2019 Feb 08; 79():37-43. PubMed ID: 30292891
    [Abstract] [Full Text] [Related]

  • 20. Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia.
    Sahle SN, Asress DT, Tullu KD, Weldemariam AG, Tola HH, Awas YA, Hagos GG, Worku MG, Misgina DK.
    BMC Res Notes; 2017 Jan 31; 10(1):74. PubMed ID: 28137314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.